Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.45% | 3.18% | -15.18% | 20.21% | 1.66% |
| Total Depreciation and Amortization | -36.67% | -35.86% | -30.08% | -13.90% | -5.88% |
| Total Amortization of Deferred Charges | -- | -- | -43.10% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 359.55% | 209.25% | 300.55% | 125.47% | 76.39% |
| Change in Net Operating Assets | -378.87% | -3,528.57% | 627.74% | 60.37% | 1,401.23% |
| Cash from Operations | -55.73% | 20.27% | 103.40% | 39.80% | 35.81% |
| Capital Expenditure | 13.51% | 70.59% | 100.00% | 100.00% | 60.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -352.59% | -113.32% | -1,313.64% | -100.00% | -13.13% |
| Cash from Investing | -354.79% | -113.44% | -1,328.56% | -100.00% | -12.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -152.59% | -200.00% | -- |
| Issuance of Common Stock | 376.81% | -88.10% | 1,029.79% | -70.88% | 2,291.52% |
| Repurchase of Common Stock | -12.50% | -39.13% | -133.33% | 50.00% | 66.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -588.89% | 83.08% | -- |
| Cash from Financing | 9,903.19% | 99.28% | 698.22% | -113.10% | 33.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,648.57% | -241.35% | 2,852.23% | -2,462.03% | 104.44% |